PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Aug-2022 IDRx Launches with $122 Million Series A Financing to Treat Cancer with Purpose-Built Precision Combination Therapies Businesswire
02-Aug-2022 Real-world Evidence Solutions Market Report 2022-2029 : Rising Focus on Personalized Healthcare & Delays in Drug Development and the Consequent Increase in Development Costs Driving Growth - ResearchAndMarkets.com Businesswire
02-Aug-2022 Sterilization Services Global Market Research Report 2022: Growing Prevalence of Hospital-Acquired Infections & Increase in Surgical Procedures and Food Sterilization Driving Growth - ResearchAndMarkets.com Businesswire
02-Aug-2022 Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID Businesswire
02-Aug-2022 Dazpak Flexible Packaging, an H.I.G. Capital Portfolio Company, Completes Acquisitions of Atlapac Corporation and the Inno-lok Division of Polymer Packaging Businesswire
02-Aug-2022 Fertility Drugs Global Market Report 2022: Increasing Rates of Infertility Across the Globe Driving Growth - ResearchAndMarkets.com Businesswire
02-Aug-2022 Global Ligase Market Report 2022: Growing Need for Ligases in Disease Treatment Driving Sector Expansion - ResearchAndMarkets.com Businesswire
02-Aug-2022 U.S. Small-Molecule APIs Market Research Report 2022: Featuring Key Players GlaxoSmithKline, Novartis, Pfizer & Others - ResearchAndMarkets.com Businesswire
02-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Aug-2022 Asia Pacific Healthcare Technology Management Market Report 2022-2028: Medical Devices and Algorithms Helping Prevent Incorrect or Delayed Diagnoses - ResearchAndMarkets.com Businesswire
02-Aug-2022 Worldwide Healthcare Customer Data Platform Industry to 2027 - North America is Expected to Hold a Significant Share in the Market - ResearchAndMarkets.com Businesswire
02-Aug-2022 Wilhelm von Haller is Chief Financial Officer of Lysando AG Businesswire
02-Aug-2022 Genentech’s Subcutaneous Formulation of Tecentriq Demonstrates Positive Phase III Results Businesswire
02-Aug-2022 Finalization of Vifor Pharma acquisition Businesswire
02-Aug-2022 Kerecis, the Medical-Fish-Skin Company, Completes $100 Million Financing from LEGO Owner KIRKBI and Others Businesswire
02-Aug-2022 Ligand Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
02-Aug-2022 CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO® Businesswire
01-Aug-2022 DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022 Businesswire
01-Aug-2022 Fabrinet to Announce Fourth Quarter and Fiscal-Year 2022 Financial Results on August 15, 2022 Businesswire
01-Aug-2022 Adicet Bio to Present at Upcoming Investor Conferences Businesswire